By searching the church's famed family trees, scientists have tracked down a cancer-causing mutation that came west with a pioneer couple—just in time to save the lives of their great-great-great-great grandchildren.
A Spotify playlist tailored to your DNA is the latest example of brands cashing in on people’s search for identity.
A four-year experiment sets out to study the ecological consequences of a bold scheme to end malaria.
A case in Washington questions how the government defines race.
Human drugs have been crucial to poultry farming. So what’s replacing them?
The “tour de force” technique is supercharging the search for dangerous genetic variants.
One hundred supposedly sick passengers ended up being only 19. But the story tapped into potent fears about flying.
A veteran conservationist reckons with his career studying animals in the most extreme places on Earth.
A hemophiliac says his genetic disorder is part of his identity, and therapies like CRISPR threaten to erase it.
Feces turn subordinates into better caretakers for the colony’s pups.
Kits from companies like 23andMe can reveal unpleasant surprises.
“A fog droplet isn’t a bad environment to live in"
The extraordinary find is rewriting the story of archaic and modern humans.
Experts still vehemently disagree over when one of the biggest eruptions of the Holocene actually happened.
A new start-up is making vegan food for dogs and lab-grown mouse meat for cats. It wants to change the way all pets eat.
“A roaring ocean of boiling jam, with the geysers of released air and steam likely ejecting at least a few berries into orbit.”
23andMe’s $300 million deal with GlaxoSmithKline is just the tip of the iceberg.
On the many attempts to repurpose a drug best known for treating erectile dysfunction
It alleged a complex web of corruption going back decades.
Fifty-thousand-year-old tools suggest that modern humans weren't prehistory's only pyros.